Skip to main content
. 2014 Nov 6;10(3):493–499. doi: 10.2215/CJN.05810614

Table 5.

Quality improvement program for 2015 and 2016

Payment year 2015 2016
Measure 6 clinical 8 clinical
 Hb > 12 g/dl  Hb > 12 g/dl
 VAT measure topic  VAT measure topic
 Catheter  Catheter
 Fistula  Fistula
 Kt/V  Kt/V
 HD  HD
 PD  PD
 Pediatric  Pediatric
4 reporting  NHSN bloodstream infections in HD outpatients
 NHSN  Hypercalcemia
 ICH CAHPS 3 reporting
 Mineral metabolism  ICH CAHPS
 Anemia management  Mineral metabolism
 Anemia management
Performance period CY 2013 CY 2014
Comparison period CY 2011 (achievement) CY 2012 (achievement)
CY 2012 (improvement) CY 2013 (improvement)
No improvement scoring for NHSN bloodstream infections
Performance standard National performance rate (CY 2011) National performance rate (CY 2012)
National performance rate (May–December 2012) for hypercalcemia
National performance rate (CY 2014) for NHSN
Weighting Clinical 75%, reporting 25% Clinical 75%, reporting 25%, hypercalcemia at two thirds of each remaining clinical measure
Maximum performance score 100 points 100 points
Minimum total performance score 60 points 54 points
Payment reduction scale 0.5%–2% with a 0.5% reduction for every 10 points under the minimum total performance score

Adapted from Centers for Medicare & Medicaid Services ESRD quality improvement project summary for payment year 2012–2016. "Clinical" means that target value needs to be achieved. "Reporting" indicates that no target value was available and credit was given for reporting results only. Hb, hemoglobin; VAT, vascular access type; HD, hemodialysis; PD, peritoneal dialysis; NHSN, National Healthcare System Network (reporting of dialysis-related infection events); ICH CAHPS, In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems; CY, Calendar Year.